ARTICLE | Company News
Pharming, Swedish Orphan Biovitrum deal
November 24, 2014 8:00 AM UTC
The companies added seven countries to an amended 2010 deal granting Swedish Orphan an exclusive 10-year license to commercialize Pharming’s Ruconest conestat alfa in 24 countries in the EU plus Norw...